Published by Long-term exposure to benzene has been linked to the development of numerous types of cancers, including acute myelogenous leukemia (AML).
Free Confidential Lawsuit Evaluation: If you or a loved one was diagnosed with acute myelogenous leukemia after being exposed to benzene, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
Table Of Contents
Update: Illinois Man Alleges Leukemia from Benzene Exposure
July 10, 2017 – A man from Wood River, Illinois, claims that he developed acute myeloid leukemia due to exposure to benzene from the Wood River Refinery.
Plaintiff Dennis Determan alleges this exposure occurred due to exposure, inhalation, ingestion, and/or absorption of benzene being emitted, leaked, spilled, dumped, and discharged into the air and surface/groundwater by manufacturing plants owned by Rust-Oleum Corporation and Turtle Wax, Inc.
What’s the Problem?
Acute myelogenous leukemia is a cancer that affects the blood and bone marrow of the body. The cancer progresses quickly and affects the blood cells that are immature causing the bone marrow to produce white blood cells that are abnormal.
These abnormal white blood cells multiply rapidly and begin to take over the space needed by the healthy blood cells. Because the white blood cells are abnormal, they are unable to perform their normal functions, leaving the body susceptible to infection and uncontrollable bleeding.
Related Article: Benzene Exposure Lawsuit Update
The initial symptoms of acute myelogenous leukemia resemble those of the flu or the common cold, causing individuals to delay treatment until the symptoms become severe or last for an extended period of time. Individuals experiencing the initial symptoms of the condition may have a fever, feel fatigued or lethargic, experience unexplainable weight loss, and may feel bone pain.
The symptoms that follow depend on the type of blood cells that the condition is primarily affecting. If the red blood cells are affected, anemia will develop and shortness of breath will occur. If the white blood cells of the body are affected, it will result in the individual being unable to fight off infections and heal properly.
If the platelets of the blood are affected, the individual may experience uncontrollable bleeding, wounds that will not clot or seal properly, and easy bruising. Acute myelogenous leukemia also has the ability to leave the blood and spread to cells throughout the body, affecting them as well.
Acute myelogenous leukemia is the most common type of leukemia and most cases of the condition respond well to treatment. The condition is diagnosed by testing the blood and bone marrow of individuals suspected of developing acute myelogenous leukemia.
Treatment should be obtained as soon as a diagnosis of acute myelogenous leukemia is confirmed as the condition progresses rapidly and can spread throughout the body as the condition worsens. The most common treatment for the condition is chemotherapy and the individual will need to be hospitalized during the treatment because chemotherapy kills many healthy cells along with the cancerous cells.
Relapses are frequent because the DNA of the cells affected by acute myelogenous leukemia is compromised. There is no effective cure for acute myelogenous leukemia and treatments are geared towards getting the condition to go into remission.
Acute myelogenous leukemia is rarely found to have a genetic cause and most cases are acquired through exposure to cancer-causing agents, such as the chemical benzene. Long-term exposure to increased levels of benzene in the air has been linked to the development of a wide variety of cancers including acute myelogenous leukemia.
Benzene is also present in cigarette smoke and has been linked to an increased risk of regular smokers developing acute myelogenous leukemia later in life. The condition is more common in individuals who are older than 60 years old and is more common in males than in females.
Related Articles:
See all related toxic tort lawsuits our lawyers covered so far.
FAQs:
What Is Acute Myelogenous Leukemia (AML)?
Acute myelogenous leukemia (AML) is a cancer that starts in the bone marrow and often moves into the blood, affecting white blood cells, red blood cells, and platelets.
What Are the Common Symptoms of Acute Myelogenous Leukemia?
The most common symptoms of Acute Myelogenous Leukemia include fatigue, fever, frequent infections, easy bruising or bleeding, shortness of breath, and weight loss.
Who Is at Risk of Developing Acute Myelogenous Leukemia?
Individuals who were exposed to chemicals like benzene, had previous cancer treatments, smoked, and had certain genetic disorders are at risk of developing Acute Myelogenous Leukemia.
What Treatment Options Are Available for Acute Myelogenous Leukemia?
Treatment options that are available for Acute Myelogenous Leukemia include chemotherapy, radiation therapy, and stem cell transplantation.
Do I have a Benzene Lawsuit?
The Toxic Tort Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Benzene lawsuits. We are handling individual and group litigation nationwide and currently accepting new Benzene cases in all 50 states.
If you or a loved one have been exposed to Benzene and developed a form of leukemia or other blood-related disease, you should contact us immediately. You may be entitled to compensation and we can help.
To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: